Company Filing History:
3 out of 238 
3 out of 6 
2 out of 155 
Years Active: 1996-2007
Title: The Innovations of Peter Herrlich
Introduction
Peter Herrlich is a notable inventor based in Karlsruhe, Germany. He has made significant contributions to the field of medicine, particularly in the development of compounds that target specific biological processes. With a total of 7 patents to his name, Herrlich's work has the potential to impact the treatment of various diseases.
Latest Patents
Among his latest patents is the invention titled "Valproic acid and derivatives thereof as histone deacetylase inhibitors." This invention focuses on the use of valproic acid and its derivatives as inhibitors of enzymes with histone deacetylase activity. The implications of this invention are profound, as it relates to the treatment of diseases associated with hypoacetylation of histones, potentially inducing differentiation and apoptosis in transformed cells. Another significant patent is the "Agent for identifying and treating metastasizing tumors," which presents a novel composition for identifying and suppressing tumor cell growth. This composition includes antibodies that react with proteins having N-glycosidically bonded saccharides, showcasing Herrlich's innovative approach to cancer treatment.
Career Highlights
Throughout his career, Peter Herrlich has worked with esteemed organizations such as the Kernforschungszentrum Karlsruhe GmbH and the Universität Karlsruhe. His experience in these institutions has allowed him to develop and refine his inventions, contributing to advancements in medical research and treatment methodologies.
Collaborations
Herrlich has collaborated with notable colleagues, including Helmut Ponta and Ursula Guenthert. These partnerships have likely enriched his research and expanded the impact of his inventions in the scientific community.
Conclusion
Peter Herrlich's contributions to the field of medicine through his innovative patents demonstrate his commitment to advancing healthcare solutions. His work continues to inspire future research and development in the treatment of complex diseases.